Schreiber S, Ben-Horin S, Leszczyszyn J, Dudkowiak R, et al. Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease. Gastroenterology 2021 Mar 4. pii: S0016-5085(21)00474.
PMID: 33676969